Minimal Residual Disease

Minimal Residual Disease (MRD) refers to the small number of cancer cells that may remain in a patient's body after treatment, even when they are in remission. These cells are not detectable using standard tests, but they can lead to a relapse of the disease. MRD testing helps doctors identify these hidden cells through advanced techniques, allowing for better monitoring and treatment adjustments. Detecting MRD is crucial for assessing the effectiveness of treatment and the risk of cancer returning, especially in blood cancers like leukemia or lymphoma.